Literature DB >> 24791829

Connective tissue disease-associated pulmonary arterial hypertension in Chinese patients.

Yan-Jie Hao1, Xin Jiang2, Wei Zhou1, Yong Wang3, Lan Gao1, Yu Wang1, Guang-Tao Li1, Tao Hong4, Yong Huo4, Zhi-Cheng Jing2, Zhuo-Li Zhang5.   

Abstract

We sought to investigate the characteristics, survival and risk factors for mortality in Chinese patients with connective tissue disease (CTD)-associated pulmonary arterial hypertension (APAH) in modern therapy era. 129 consecutive adult patients who visited one of three referral centres in China with a diagnosis of CTD-APAH confirmed by right heart catheterisation during the previous 5 years were enrolled. The end-point was all-cause death or data censoring. Systemic lupus erythematosus was the most common underlying CTD (49%) and systemic sclerosis just accounted for 6% in this cohort. The overall survival at 1 and 3 years was 92% and 80%, respectively. Pericardial effusion, a shorter 6-min walk distance, lower mixed venous oxygen saturation, higher pulmonary vascular resistance (PVR) and alkaline phosphatase (ALP), and lower total cholesterol levels were all associated with a higher risk of death among the study population. Higher PVR and ALP were independent predictors of mortality. In conclusion, unlike in western patients, systemic lupus erythematosus is the most common underlying disease in Chinese patients with CTD-APAH. The survival of Chinese patients with CTD-APAH in the modern treatment era is similar to that in western countries. Elevated PVR and ALP are independent risk factors for poor outcomes. ©ERS 2014.

Entities:  

Mesh:

Year:  2014        PMID: 24791829     DOI: 10.1183/09031936.00182813

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  22 in total

1.  Selective Sexual Dimorphisms in Musculoskeletal and Cardiopulmonary Pathologic Manifestations and Mortality Incidence in the Tumor Necrosis Factor-Transgenic Mouse Model of Rheumatoid Arthritis.

Authors:  Richard D Bell; Emily K Wu; Christopher A Rudmann; Megan Forney; Claire R W Kaiser; Ronald W Wood; Joe V Chakkalakal; Nicole D Paris; Alanna Klose; Guang-Qian Xiao; Javier Rangel-Moreno; Maria L Garcia-Hernandez; Christopher T Ritchlin; Edward M Schwarz; Homaira Rahimi
Journal:  Arthritis Rheumatol       Date:  2019-07-22       Impact factor: 10.995

2.  Abnormal Liver Function Tests Were Related to Short- and Long-Term Prognosis in Critically Ill Patients With Primary Pulmonary Hypertension.

Authors:  Dayu Wang; Suiqing Huang; Guangtao Xu; Sha Wu; Zhen Liu; Long Xu; Bo Hu; Jian Hou
Journal:  Front Cardiovasc Med       Date:  2022-06-02

3.  Is it possible to apply the treat-to-target strategy in primary Sjögren's syndrome-associated pulmonary arterial hypertension?

Authors:  Ziwei Liu; Jieying Wang; Jinzhi Lai; Qian Wang; Jiuliang Zhao; Can Huang; Xiaoxi Yang; Junyan Qian; Hui Wang; Xiaoxiao Guo; Yongtai Liu; Zhuang Tian; Mengtao Li; Yan Zhao; Xiaofeng Zeng
Journal:  Clin Rheumatol       Date:  2018-07-24       Impact factor: 2.980

4.  Tetramethylpyrazine: A promising drug for the treatment of pulmonary hypertension.

Authors:  Yuqin Chen; Wenju Lu; Kai Yang; Xin Duan; Mengxi Li; Xiuqing Chen; Jie Zhang; Meidan Kuang; Shiyun Liu; Xiongting Wu; Guofa Zou; Chunli Liu; Cheng Hong; Wenjun He; Jing Liao; Chi Hou; Zhe Zhang; Qiuyu Zheng; Jiyuan Chen; Nuofu Zhang; Haiyang Tang; Rebecca R Vanderpool; Ankit A Desai; Franz Rischard; Stephen M Black; Joe G N Garcia; Ayako Makino; Jason X-J Yuan; Nanshan Zhong; Jian Wang
Journal:  Br J Pharmacol       Date:  2020-04-27       Impact factor: 8.739

5.  Simplified risk stratification for pulmonary arterial hypertension associated with connective tissue disease.

Authors:  Xiaodi Li; Xiaoxuan Sun; Yingheng Huang; Yuanyuan Wang; Xiaoman Yang; Jingya Wang; Ning Zhang; Lei Gu; Miaojia Zhang; Qiang Wang
Journal:  Clin Rheumatol       Date:  2019-08-05       Impact factor: 2.980

6.  Clinical characteristics and survival of patients with three major connective tissue diseases associated with pulmonary hypertension: A study from China.

Authors:  Jie Pan; Ling Lei; Cheng Zhao; Jing Wen; Fang Qin; Fei Dong
Journal:  Exp Ther Med       Date:  2021-06-30       Impact factor: 2.447

Review 7.  Successful Early Immunosuppressive Therapy for Pulmonary Arterial Hypertension Due to Takayasu arteritis: Two Case Reports and a Review of Similar Case Reports in the English Literature.

Authors:  Takuya Suda; Takeshi Zoshima; Kiyoaki Ito; Ichiro Mizushima; Mitsuhiro Kawano
Journal:  Intern Med       Date:  2021-11-13       Impact factor: 1.282

Review 8.  Long-term survival and death causes of systemic lupus erythematosus in China: a systemic review of observational studies.

Authors:  Ziqian Wang; Yanhong Wang; Rongrong Zhu; Xinping Tian; Dong Xu; Qian Wang; Chanyuan Wu; Shangzhu Zhang; Jiuliang Zhao; Yan Zhao; Mengtao Li; Xiaofeng Zeng
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

9.  Connective Tissue Disease-Associated Pulmonary Arterial Hypertension in Southern Taiwan: A Single-Center 10-Year Longitudinal Observation Cohort.

Authors:  Chun-Hsin Wu; Chun-Yu Lin; Chih-Hsin Hsu; Sheng-Hsiang Lin; Chia-Tse Weng
Journal:  Healthcare (Basel)       Date:  2021-05-20

10.  Pediatric Pulmonary Hypertension: Definitions, Mechanisms, Diagnosis, and Treatment.

Authors:  Devashis Mukherjee; Girija G Konduri
Journal:  Compr Physiol       Date:  2021-06-30       Impact factor: 8.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.